613
Participants
Start Date
October 1, 2020
Primary Completion Date
September 6, 2022
Study Completion Date
September 6, 2022
AZD5718
Participants will receive once daily oral dose of AZD5718 as per the arms they are randomised, and will continue until Week 20.
Dapagliflozin 10 mg
Participants will receive once daily oral dose of 10 mg dapagliflozin for 8 weeks as an add-on therapy.
Placebo
Participants will receive once daily oral dose of placebo matched to AZD5718, and will continue until Week 20.
Research Site, Taipei
Research Site, Taipei
Research Site, Taichung
Research Site, Kaohsiung City
Research Site, Kyiv
Research Site, Budapest
Research Site, Budapest
Research Site, Buenos Aires
Research Site, Debrecen
Research Site, Córdoba
Research Site, Junín
Research Site, Szentes
Research Site, Szigetvár
Research Site, Balatonfüred
Research Site, Zhytomyr
Research Site, Great Neck
Research Site, Fresh Meadows
Research Site, Jamaica
Research Site, Berlin
Research Site, Keelung
Research Site, Vinnytsia
Research Site, Vinnytsia
Research Site, New Taipei City
Research Site, Columbus
Research Site, Seri Manjung
Research Site, Jacksonville
Research Site, Winter Haven
Research Site, Haifa
Research Site, Taichung
Research Site, Taichung
Research Site, Essen
Research Site, Blue Ash
Research Site, Roseville
Research Site, Dnipro
Research Site, Dnipro
Research Site, Kuala Lumpur
Research Site, Trier
Research Site, Kuala Lumpur
Research Site, Kuala Lumpur
Research Site, Hazelwood
Research Site, Aschaffenburg
Research Site, Zaporizhzhia
Research Site, Seremban
Research Site, Ivano-Frankivsk
Research Site, Ivano-Frankivsk
Research Site, Houston
Research Site, Pearland
Research Site, Schertz
Research Site, San Antonio
Research Site, Malacca
Research Site, Ashkelon
Research Site, Austin
Research Site, Lviv
Research Site, Denver
Research Site, Kaohsiung City
Research Site, Uzhhorod
Research Site, Kota Kinabalu
Research Site, Jerusalem
Research Site, Canoga Park
Research Site, La Mesa
Research Site, Victorville
Research Site, San Carlos
Research Site, San Francisco
Research Site, Sibu
Research Site, Afula
Research Site, Ashdod
Research Site, East Providence
Research Site, Memphis
Research Site, Bahía Blanca
Research Site, Córdoba
Research Site, Córdoba
Research Site, Mar del Plata
Research Site, Belém
Research Site, Brasília
Research Site, Curitiba
Research Site, Fortaleza
Research Site, Meireles
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Santo André
Research Site, São Paulo
Research Site, São Paulo
Research Site, São Paulo
Research Site, Ageo
Research Site, Asahikawa-shi
Research Site, Chiba
Research Site, Hiroshima
Research Site, Kasugai-shi
Research Site, Kitakyushu
Research Site, Koga-shi
Research Site, Kyoto
Research Site, Mito
Research Site, Morioka
Research Site, Osaka
Research Site, Osaka
Research Site, Osaka
Research Site, Sashima-gun
Research Site, Shizuoka
Research Site, Toride-shi
Research Site, Yokohama
Research Site, Yokohama
Research Site, Yokohama
Research Site, Bialystok
Research Site, Bialystok
Research Site, Krakow
Research Site, Lodz
Research Site, Oświęcim
Research Site, Rzeszów
Research Site, Taipei
Research Site, Kyiv
Research Site, Kyiv
Lead Sponsor
Collaborators (2)
Parexel
INDUSTRY
Emerald Clinical Inc.
INDUSTRY
AstraZeneca
INDUSTRY